HPV Vaccine Guidance Shifts to Single-Dose Schedule
Medical experts are weighing whether one HPV vaccine dose is sufficient, even as the current recommendation remains two doses for children.
- Nearly 50,000 U.S. cancer cases annually are linked to HPV infections.
- 90% of cervical and anal cancers are attributed to HPV, per the CDC.
- Vaccinated males are nearly 50% less likely to develop head, neck, or anal cancers.
- 63% of U.S. teenagers have received both doses; that rate has been flat four years running.
Why it matters: A Costa Rica study tracked more than 20,000 girls over five years and found one dose delivered about 97% protection against cervical cancer — comparable to two doses. Jason Schwartz, a Yale vaccine policy researcher, called a potential shift to one dose 'a significant change in what has been communicated for many years.'
- Evidence for one dose is strongest for girls and cervical cancer; data on other cancers and on males is thinner.
- Angela Ulrich of the University of Minnesota's Vaccine Integrity Project noted protection persists into a patient's 40s.
How 5 sources split on this story
Where they split: The core dispute is whether the one-dose evidence is broad enough — covering males, age groups, and cancer types beyond cervical — to justify updating official recommendations.
Center coverage, 3 sources: The center presents the dosing question as a straightforward public-health explainer, noting the policy turbulence without foregrounding Kennedy's role or motives.
Left coverage, 1 sources: The left frames the dosing debate inside a broader story of institutional conflict, highlighting Kennedy's prior litigation against Gardasil's maker and his false claim that the vaccine raises cervical cancer risk.
What’s next: The American Academy of Pediatrics is reviewing whether one dose suffices for at least some patients, said Dr. James Campbell, chair of its infectious diseases committee.
- A CDC advisory committee work group examining revised dosing was disbanded when Health Secretary Robert F. Kennedy Jr. removed its members.
- Will the American Academy of Pediatrics formally lower the recommended dose count, and on what timeline?
- Does one dose provide comparable protection for males and for cancers beyond cervical?
- How would a one-dose change affect the flat 63% vaccination rate?